ARK Genomic Revolution ETF (ARKG)

Cboe BZX: ARKGExchange-traded fund from ARK ETF Trust.

  • Expense ratio0.71%
  • Net assets$2.16B
  • Dividend yield0.00%
  • 1-year return+45.01%
  • Holdings33

ARKG ETF price chart

ARKG quote & trading statistics

  • YTD+69.56%
  • 1 year+45.01%
  • 3 years+27.00%/yr
  • 5 years-7.93%/yr
  • 10 years+11.06%/yr
1Y volatility
40.56%
3Y volatility
42.14%
3Y Sharpe ratio
0.63

Returns include reinvested distributions; 3-, 5- and 10-year figures are annualized.

ARKG top 10 holdings

All holdings →
ARK Genomic Revolution ETF largest holdings by weight
#SymbolNameWeight
1TXG10X Genomics Inc8.83%
2TEMTempus AI, Inc. Class A Common Stock8.15%
3TWSTTwist Bioscience Corp7.80%
4CRSPCrispr Therapeutics AG5.58%
5NTRANatera Inc5.08%
6ILMNIllumina Inc5.03%
7GHGuardant Health Inc4.97%
8ABSIAbsci Corp4.63%
9LLYEli Lilly and Company4.30%
10CDNACareDx Inc3.92%

The top 10 holdings make up 58.3% of the fund (33 holdings in total). As of October 23, 2026.

ARKG sector weights

Healthcare
100.0%

ARKG region weights

North America
88.1%
Europe Developed
5.4%
United Kingdom
2.9%

ARKG asset allocation

U.S. stocks
89.4%
Non-U.S. stocks
8.0%
Cash
0.7%

ARKG market-cap breakdown

Micro cap
42.4%
Small cap
30.7%
Mid cap
20.0%
Mega cap
4.2%

About ARK Genomic Revolution ETF

The fund is an actively-managed exchange-traded fund (ETF) that will invest under normal circumstances primarily (at least 80% of its assets) in domestic and foreign equity securities of companies across multiple sectors, including healthcare, information technology, materials, energy and consumer discretionary, that are relevant to the fund's investment theme of the genomics revolution (Genomics Revolution Companies). It is non-diversified.

ARKG ETF FAQ

What is the ARKG expense ratio?

ARK Genomic Revolution ETF has a net expense ratio of 0.71%, or $71.00 a year for every $10,000 invested.

How much money is in ARKG?

ARK Genomic Revolution ETF has about $2.16B in net assets.

What are the top holdings of ARKG?

The largest positions in ARKG are 10X Genomics Inc (8.83%), Tempus AI, Inc. Class A Common Stock (8.15%), Twist Bioscience Corp (7.80%). The fund holds 33 securities in total.

How has ARKG performed?

ARKG returned +45.01% over the past year and -7.93% a year over the past five years, including reinvested distributions.

Does ARKG pay dividends?

ARKG has a dividend yield of 0.00%.

When was ARKG launched?

ARK Genomic Revolution ETF began trading on October 31, 2014.